Sort   by:  
 Page size 
UnknownThe Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.
Not available
S-EPMC2423262 | biostudies-literature
UnknownPathways to Parkinson's disease: a spotlight on 14-3-3 proteins.
Not available
S-EPMC8455551 | biostudies-literature
UnknownParkinson's disease and immune system: is the culprit LRRKing in the periphery?
Not available
S-EPMC3391996 | biostudies-literature
UnknownGenetic, structural, and molecular insights into the function of ras of complex proteins domains.
Not available
S-EPMC4104024 | biostudies-literature
UnknownEditorial: LRRK2-Fifteen Years From Cloning to the Clinic.
Not available
S-EPMC9036085 | biostudies-literature
UnknownBrain changes in Kallmann syndrome.
Not available
S-EPMC7966280 | biostudies-literature
UnknownStructure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase.
Not available
S-EPMC2234173 | biostudies-literature
UnknownSecretion-Positive LGI1 Mutations Linked to Lateral Temporal Epilepsy Impair Binding to ADAM22 and ADAM23 Receptors.
Not available
S-EPMC5070869 | biostudies-literature
UnknownGenetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging.
Not available
S-EPMC4194318 | biostudies-literature
UnknownAlpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells.
Not available
S-EPMC2851596 | biostudies-literature
Sort   by:  
 Page size